| Identification | Back Directory | [Name]
Methanone, (4,6-diMethyl-5-pyriMidinyl)[4-[(3S)-4-[(1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoroMethyl)-1H-inden-1-yl]-3-Methyl-1-piperazinyl]-4-Methyl-1-piperidinyl]-, (Hydrochloride) (1:2) | [CAS]
869725-27-9 | [Synonyms]
INCB009471
INCB-009471
INCB 009471
INCB-9471(HCl)
INCB 9471 HCl,INCB9471 HCl
(4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone:dihydrochloride
Methanone, (4,6-diMethyl-5-pyriMidinyl)[4-[(3S)-4-[(1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoroMethyl)-1H-inden-1-yl]-3-Methyl-1-piperazinyl]-4-Methyl-1-piperidinyl]-, (Hydrochloride) (1:2) | [Molecular Formula]
C30H41ClF3N5O2 | [MDL Number]
MFCD18782691 | [MOL File]
869725-27-9.mol | [Molecular Weight]
596.14 |
| Hazard Information | Back Directory | [Uses]
CCR5 antagonist 5 (compound example 11) is a CCR5 antagonist. CCR5 antagonist 5 has the potential to study inflammation and immunity and viral (such as HIV) infection[1]. | [References]
[1] Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity
ACC MCL Publication Date (Web): August 25, 2010 (Letter)
[2] Chu-Biao Xue, et al. Piperazinylpiperidine derivatives as chemokine receptor antagonists. US20050261310A1. |
|
|